Interv Akut Kardiol. 2020;19(3):176-178 | DOI: 10.36290/kar.2020.035
ACE inhibitors and beta-blocking agents have an irreplaceable role in various indications in cardiology, including hypertension, heart failure, secondary prevention in coronary heart disease, especially after acute coronary syndromes. They can be successfully used in other indications, too. Patient prognosis can be influenced at various levels, which however means higher numbers of drugs used. In recent years, we have witnessed trends in drug manufacturers to bring to the market pills with two or three complementary substances. One of them - a fixed combination of a beta-blocking agent and an ACE inhibitor - is unique and its name is COSYREL®.
Received: August 6, 2020; Revised: August 6, 2020; Accepted: August 6, 2020; Prepublished online: August 6, 2020; Published: September 2, 2020 Show citation